Land JAZZ Even Cheaper Than Its Secondary?
March 07, 2013 at 12:08 PM EST
Looking back to 2 days ago, Jazz Pharmaceuticals plc (JAZZ) priced a 5,375,000 share secondary stock offering at $58.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time.